Sequoia Financial Advisors LLC Has $2.30 Million Position in Colgate-Palmolive (NYSE:CL)

Sequoia Financial Advisors LLC grew its stake in Colgate-Palmolive (NYSE:CL - Free Report) by 24.0% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 25,286 shares of the company's stock after acquiring an additional 4,894 shares during the period. Sequoia Financial Advisors LLC's holdings in Colgate-Palmolive were worth $2,299,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds have also modified their holdings of the stock. FMR LLC grew its position in shares of Colgate-Palmolive by 65.6% during the 3rd quarter. FMR LLC now owns 6,749,275 shares of the company's stock worth $700,642,000 after buying an additional 2,674,807 shares during the period. AMF Tjanstepension AB grew its holdings in Colgate-Palmolive by 1,088.8% during the 4th quarter. AMF Tjanstepension AB now owns 2,569,394 shares of the company's stock worth $233,584,000 after acquiring an additional 2,353,268 shares during the period. Barclays PLC raised its position in shares of Colgate-Palmolive by 38.7% during the 3rd quarter. Barclays PLC now owns 7,644,189 shares of the company's stock valued at $793,542,000 after acquiring an additional 2,132,747 shares during the last quarter. State Street Corp lifted its stake in shares of Colgate-Palmolive by 3.8% in the 3rd quarter. State Street Corp now owns 48,436,276 shares of the company's stock valued at $5,028,170,000 after purchasing an additional 1,784,411 shares during the period. Finally, Raymond James Financial Inc. bought a new position in shares of Colgate-Palmolive in the 4th quarter worth $132,405,000. 80.41% of the stock is owned by institutional investors.

Remove Ads

Wall Street Analyst Weigh In

Several equities analysts have weighed in on the company. Raymond James reissued an "outperform" rating and issued a $105.00 target price (down previously from $110.00) on shares of Colgate-Palmolive in a research note on Monday, February 3rd. StockNews.com lowered shares of Colgate-Palmolive from a "buy" rating to a "hold" rating in a research note on Friday, March 14th. Morgan Stanley lowered their target price on shares of Colgate-Palmolive from $111.00 to $104.00 and set an "overweight" rating for the company in a research note on Monday, February 3rd. TD Cowen reduced their price target on shares of Colgate-Palmolive from $110.00 to $100.00 and set a "buy" rating on the stock in a research report on Wednesday, January 8th. Finally, UBS Group lowered their price objective on shares of Colgate-Palmolive from $104.00 to $100.00 and set a "buy" rating for the company in a research report on Monday, February 3rd. One investment analyst has rated the stock with a sell rating, ten have assigned a hold rating and eleven have issued a buy rating to the company. According to MarketBeat, the company presently has an average rating of "Hold" and a consensus price target of $101.72.

Colgate-Palmolive Stock Up 1.1 %

CL traded up $0.95 during trading hours on Wednesday, hitting $90.44. 7,984,373 shares of the company's stock were exchanged, compared to its average volume of 4,191,857. The stock has a market cap of $73.39 billion, a price-to-earnings ratio of 25.69, a PEG ratio of 4.20 and a beta of 0.40. Colgate-Palmolive has a 1-year low of $85.32 and a 1-year high of $109.30. The stock's 50-day moving average is $89.13 and its two-hundred day moving average is $94.44. The company has a quick ratio of 0.58, a current ratio of 0.92 and a debt-to-equity ratio of 13.40.

Colgate-Palmolive (NYSE:CL - Get Free Report) last posted its quarterly earnings data on Friday, January 31st. The company reported $0.91 EPS for the quarter, topping analysts' consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. During the same quarter in the prior year, the business posted $0.87 earnings per share. Sell-side analysts predict that Colgate-Palmolive will post 3.75 earnings per share for the current fiscal year.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.